altretamine has been researched along with Cancer, Embryonal in 2 studies
Altretamine: A hexamethyl-2,4,6-triamine derivative of 1,3,5-triazine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, BW | 1 |
| Goldhirsch, A | 1 |
| Locher, GW | 1 |
| Dreher, E | 1 |
| Greiner, R | 1 |
| Burki, K | 1 |
| Brunner, KW | 1 |
| Grosh, WW | 1 |
| Jones, HW | 1 |
| Burnett, LS | 1 |
| Greco, FA | 1 |
2 other studies available for altretamine and Cancer, Embryonal
| Article | Year |
|---|---|
Pathologic data of prognostic significance for remission induction in advanced ovarian carcinoma.
Topics: Adenocarcinoma; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluat | 1984 |
Malignant mixed mesodermal tumors of the uterus and ovary treated with cisplatin-based combination chemotherapy.
Topics: Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxo | 1986 |